|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 6 of 19 found articles
| Title: |
Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial |
| Author: |
Daar, Eric S DeJesus, Edwin Ruane, Peter Crofoot, Gordon Oguchi, Godson Creticos, Catherine Rockstroh, Jürgen K Molina, Jean-Michel Koenig, Ellen Liu, Ya-Pei Custodio, Joseph Andreatta, Kristen Graham, Hiba Cheng, Andrew Martin, Hal Quirk, Erin |
| Appeared in: |
The Lancet. HIV |
| Paging: | Volume 5 () nr. 7 pages e347-e356 |
| Year: |
2018 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 6 of 19 found articles
| << previous | next >> |